American Academy of Dermatology

Lio delves into his American Academy of Dermatology Annual Meeting session, "Dietary Triggers and Modifications of Common Dermatologic Conditions: An Evidence Based Approach."

Catch up on coverage from the first day of the 2024 American Academy of Dermatology Annual Meeting.

Jason S. Reichenberg, MD, MBA, FAAD, shares tips for improving interactions and communications at the 2024 AAD Annual Meeting.

How can you improve excision care for your patients with hidradenitis suppurativa? Ashley Nicole Elsensohn, MD, MPH, FAAD, shared clinical pearls at the AAD Annual Meeting.

Neal Bhatia, MD, shares his insights on successfully navigating AAD and his session highlights on office politics.

Chovatiya acknowledged the common sentiment among residents who, despite dedicating significant time to studying and working during residency, may feel unprepared.

"We cannot do health equity outside of an institution unless we figure out how to get our own house in order," the AMA leader said.

The 20th Annual Skin of Color Society Scientific Symposium featured diverse research including studies on traction alopecia among individuals with religious head coverings, challenges in color-matching universal tinted sunscreens, dermatologic disparities in American Indian/Alaskan Native populations, and more.

April W. Armstrong, MD, MPH, shared treatment insights with attendees at the 36th Annual Pre-AAD Meeting of the Society for Pediatric Dermatology.

New data was presented at the American Academy of Dermatology Annual Meeting in San Diego, California.

Maggi Ahmed, MD, PhD, demonstrated superior pigmentation outcomes and reduced CD8+ T cell numbers in her recent research results.

Click here to answer our poll and let us know what disease states, topics, and research you most want to see news about throughout the conference.

Read more on what you can expect at this year’s AAD meeting and how to navigate all the opportunities.

Kelly M. Cordoro, MD, shared tips on implementing shared decision making in pediatric dermatology dermatology atat annual conference.

Dermatology Times chatted with Sonya Kenkare, MD, FAAD, for tips on navigating the annual meeting.

We've rounded up commentary from trusted dermatology experts who expressed enthusiasm and excitement for the biggest dermatology meeting of the year.

The organization celebrates 2 decades of leading awareness, research, education, membership, and advocacy for clinicians and patients with skin of color.

Among the many sessions to be held at the American Academy of Dermatology Annual Meeting in San Diego, California, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

There are several events in conjunction with AAD featuring opportunities for dermatology clinicians to gain CME credit, network, explore career options, and gain pearls to put into practice.

Most of the patients receiving the non-surgical treatment experienced a complete clearing of tumors.

Immune checkpoint inhibitor therapy does not appear to increase complication rates in patients undergoing dermatologic procedures, according to a video oral abstract presentation at the 2022 ASDS Annual Meeting.

Allergic contact dermatitis and atopic dermatitis are common causes of rashes in the pediatric population. Patch testing can help demystify the cause of such skin conditions and determine treatment.

The results from the Evelo Biosciences EDP1815 treatment provide the first demonstration in a phase 2 trial of the safety and efficacy of an orally-administered, gut-restricted SINTAX medicine.

LEO Pharma presented long-term data from an interim analysis of its ECZTEND 5-year extension trial, showing no new safety signals.

What are the best post- and pre-lightening products and strategies for optimal results on all skin types? Renata Block, president of the Society of Dermatology Physician Assistants, walked through her pearls in this interview at the American Academy of Dermatology 2022 Annual Meeting.

Renata Block, MMS, PA-C, president of the Society of Dermatology Physician Assistants (PAs) talked with Dermatology Times® at the American Academy of Dermatology 2022 Annual Meeting about the broadening opportunities for these advanced health care providers to help fill the demand gap for treatment of skin and hair disorders as well as aesthetic services.

A poster from the 2022 American Academy of Dermatology Annual Meeting gathered the real-world data around patients using dupilumab to treat atopic dermatitis.

A poster from the 2022 American Academy of Dermatology Annual Meeting presented subgroup analyses from the Effisayil 1 study that showed the efficacy of spesolimab was consistent across all prespecified patient populations, including those with or without IL-36RN mutations.

VisualDX uses diverse imagery to help increase knowledge of disease manifestations in a range of skin types.

In this fourth part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, talks about what to look forward to in treatment and clinical trials of merkel cell carcinoma (MCC).